Literature DB >> 16545935

Increasing trend in the prevalence of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal ampC gene at a Korean university hospital from 2002 to 2004.

Wonkeun Song1, Jae-Seok Kim, Han-Sung Kim, Dongeun Yong, Seok Hoon Jeong, Min-Jeong Park, Kyu Man Lee.   

Abstract

The aim of the study is to investigate the prevalence of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae naturally lacking chromosomal AmpC beta-lactamases. A total of 1860 clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis were collected from a Korean hospital between January 2002 and December 2004. For the isolates that are nonsusceptible to cefoxitin, polymerase chain reaction amplification of the bla(SHV), bla(TEM), and bla(AmpC) genes and sequencing were performed. Plasmid-mediated AmpC beta-lactamases were found in 2.9% (37 isolates of DHA-1, 1 isolate of CMY-1, 1 isolate of CMY-2, and 1 isolate of ACT-1) of Klebsiella pneumoniae, 2.5% (5 isolates of DHA-1) of Klebsiella oxytoca, 0.8% (1 isolate of DHA-1) of Salmonella spp., and none of P. mirabilis isolates. The DHA-1-producing K. pneumoniae was only 2 isolates (0.6%) in 2002, but the rate and the number significantly increased to 2.4% (13 of 538 isolates) in 2003 and to 4.3% (22 of 512) in 2004. In conclusion, DHA-1 is the most prevalent plasmid-mediated AmpC beta-lactamase in Enterobacteriaceae lacking chromosomal ampC gene, and the DHA-1-producing K. pneumoniae isolates have rapidly increased since 2003 in a Korean hospital. In addition, this is the first report of the appearance of a K. pneumoniae isolate producing ACT-1 beta-lactamase in Korea.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16545935     DOI: 10.1016/j.diagmicrobio.2006.01.012

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  21 in total

1.  Chromosome-encoded AmpC and CTX-M extended-spectrum β-lactamases in clinical isolates of Proteus mirabilis from Korea.

Authors:  Wonkeun Song; Juwon Kim; Il Kwon Bae; Seok Hoon Jeong; Young Hee Seo; Jong Hee Shin; Sook Jin Jang; Young Uh; Jeong Hwan Shin; Mi-Kyung Lee; Kyungwon Lee
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

2.  Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain.

Authors:  E Miró; J Agüero; M N Larrosa; A Fernández; M C Conejo; G Bou; J J González-López; N Lara; L Martínez-Martínez; A Oliver; B Aracil; J Oteo; A Pascual; J Rodríguez-Baño; L Zamorano; F Navarro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09-07       Impact factor: 3.267

3.  Antibiotic resistance patterns and detection of blaDHA-1 in Salmonella species isolates from chicken farms in South Korea.

Authors:  Nabin Rayamajhi; Byeong Yeal Jung; Seung Bin Cha; Min Kyung Shin; Aeran Kim; Min Su Kang; Kang Mu Lee; Han Sang Yoo
Journal:  Appl Environ Microbiol       Date:  2010-06-04       Impact factor: 4.792

4.  Laboratory surveillance for prospective plasmid-mediated AmpC beta-lactamases in the Kinki region of Japan.

Authors:  Katsutoshi Yamasaki; Masaru Komatsu; Noriyuki Abe; Saori Fukuda; Yugo Miyamoto; Takeshi Higuchi; Tamotsu Ono; Hisaaki Nishio; Noriyuki Sueyoshi; Kaneyuki Kida; Kaori Satoh; Masahiro Toyokawa; Isao Nishi; Masako Sakamoto; Masahiro Akagi; Isako Nakai; Tomomi Kofuku; Tamaki Orita; Yasunao Wada; Takumi Jikimoto; Shohiro Kinoshita; Kazuaki Miyamoto; Itaru Hirai; Yoshimasa Yamamoto
Journal:  J Clin Microbiol       Date:  2010-07-07       Impact factor: 5.948

5.  Molecular analysis of a prolonged spread of Klebsiella pneumoniae co-producing DHA-1 and SHV-12 β-lactamases.

Authors:  Young Kyung Yoon; Hye Won Cheong; Hyunjoo Pai; Kyoung Ho Roh; Jeong Yeon Kim; Dae Won Park; Jang Wook Sohn; Seung Eun Lee; Byung Chul Chun; Hee Sun Sim; Min Ja Kim
Journal:  J Microbiol       Date:  2011-06-30       Impact factor: 3.422

6.  The Beta Lactam Antibiotics as an Empirical Therapy in a Developing Country: An Update on Their Current Status and Recommendations to Counter the Resistance against Them.

Authors:  Bhaskar Thakuria; Kingshuk Lahon
Journal:  J Clin Diagn Res       Date:  2013-06-01

7.  Long-term dissemination of acquired AmpC β-lactamases among Klebsiella spp. and Escherichia coli in Portuguese clinical settings.

Authors:  F Freitas; E Machado; T G Ribeiro; Â Novais; L Peixe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-10-07       Impact factor: 3.267

8.  The prevalence of plasmid-mediated AmpC beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from five children's hospitals in China.

Authors:  H Ding; Y Yang; Q Lu; Y Wang; Y Chen; L Deng; A Wang; Q Deng; H Zhang; C Wang; L Liu; X Xu; L Wang; X Shen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-01       Impact factor: 3.267

9.  First outbreak of multidrug-resistant Klebsiella pneumoniae producing both SHV-12-type extended-spectrum beta-lactamase and DHA-1-type AmpC beta-lactamase at a Korean hospital.

Authors:  Kyoung Ho Roh; Young Uh; Jae-Seok Kim; Han-Sung Kim; Dong Hoon Shin; Wonkeun Song
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759

10.  CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum beta-lactamase in clinical isolates of Escherichia coli from Korea.

Authors:  Wonkeun Song; Hyukmin Lee; Kyungwon Lee; Seok Hoon Jeong; Il Kwon Bae; Jae-Seok Kim; Hyo-Sun Kwak
Journal:  J Med Microbiol       Date:  2009-02       Impact factor: 2.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.